Regenxbio Inc (RGNX) earnings · rev $170.4M
These earnings events as JSON? API free 100/dayRegenxbio Inc (RGNX) is a biotechnology company listed on US.
This RGNX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported RGNX revenue for 2025-12-31 was $170.4M. Net income was -$193.9M. Revenue was up 104.5% from 2024-12-31 to 2025-12-31. RGNX currently screens at market cap $440.4M.
When the next RGNX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 104.5% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full RGNX research stays on the stock page; the tape stays on the quote page.
RGNX earnings FAQ
What are RGNX's latest revenue and net income?
Latest cached Regenxbio Inc (RGNX) revenue for Dec 31, 2025 was $170.4M. Net income was -$193.9M. Statements: https://lician.com/financials/rgnx
What is RGNX's latest diluted EPS?
Latest cached Regenxbio Inc (RGNX) diluted EPS for Dec 31, 2025 was -$3.76.
What period does the latest RGNX earnings print cover?
The latest cached Regenxbio Inc (RGNX) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did RGNX revenue change from the prior cached period?
Cached Regenxbio Inc (RGNX) revenue was up 104.5% from $83.3M (Dec 31, 2024) to $170.4M (Dec 31, 2025). Statements: https://lician.com/financials/rgnx
Where are RGNX earnings listed?
Cached earnings facts for Regenxbio Inc (RGNX) are listed at https://lician.com/earnings/rgnx. Statements: https://lician.com/financials/rgnx
Not investment advice.